To amend the Internal Revenue Code of 1986 to establish the generic drugs and biosimilars production credit, and for other purposes.
No official summary available for this bill.
Introduced in House
Introduced in House
Referred to the House Committee on Ways and Means.
Referred to the Subcommittee on Health.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line